Clinical Research Directory
Browse clinical research sites, groups, and studies.
REBOA in Nontraumatic OHCA
Sponsor: Seoul National University Hospital
Summary
The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
Official title: Effect Of Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-Traumatic Out-of-Hospital Cardiac Arrest (REBOA); A Multinational, Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
234
Start Date
2023-10-17
Completion Date
2026-10-01
Last Updated
2025-01-28
Healthy Volunteers
No
Conditions
Interventions
REBOA
Resuscitative endovascular balloon occlusion of the aorta (REBOA)is a device composed of a catheter attached to an inflatable balloon. It is inserted through the common femoral artery and guided to the thoracic aorta.
Locations (1)
Seoul National Univeristy Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea